摘要
目的:观察酪酸梭菌活菌辅助治疗肠易激综合征的临床疗效。方法:选取2007年4月至2010年3月收治的184例肠易激综合征患者,随机分为观察组(酪酸梭菌活菌辅助治疗组)和对照组(常规治疗组)各92例,比较两组患者的治疗效果。结果:观察组显效51例,有效37例,总有效率为95.7%;对照组显效32例,有效41例,总有效率为79.3%,两组比较差异具有统计学意义(P<0.01)。两组患者在治疗过程中均未发现明显不良反应。结论:酪酸梭菌活菌辅助治疗肠易激综合征效果理想,值得临床推广使用。
Objective：To observe the effects of Clostridium butyricum in adjuvant treatment of patients with irritable bowel syndrome（IBS）.Methods： From April of 2007 to March of 2010,184 patients with IBS were recruited and were randomly divided into observation group（treated with Clostridium butyricum） and control group.Each group had 92 cases,and the treatment effects were compared.Results： In observation group,marked improvement and active treatment were seen in 51,and 37 cases,respectively.The total effective rate was 95.7 %.In control group,marked improvement and active treatment were seen in 32,and 41 cases,respectively.The total effective rate was 79.3 %.A significant difference was seen in effective rate between two groups,and no significant adverse reactions were seen in either group.Conclusion： The adjuvant treatment of IBS with Clostridium butyricum is successful and worthy of clinical use
出处
《包头医学院学报》
CAS
2011年第2期51-52,共2页
Journal of Baotou Medical College
关键词
酪酸梭菌活菌
肠易激综合征
治疗
Clostridium butyricum
Irritable bowel syndrome
Treatment
